ABMT (Advanced BioMedical Technologies) LT-Debt-to-Total-Asset: 0.00 (As of Jul. 2021)


What is Advanced BioMedical Technologies LT-Debt-to-Total-Asset?

Advanced BioMedical Technologies ABMT LT-Debt-to-Total-Asset is 0.00 as of Jul. 2021.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Advanced BioMedical Technologies's long-term debt to total assests ratio for the quarter that ended in Jul. 2021 was 0.00.

Advanced BioMedical Technologies's long-term debt to total assets ratio declined from Jul. 2020 (0.04) to Jul. 2021 (0.00). It may suggest that Advanced BioMedical Technologies is progressively becoming less dependent on debt to grow their business.

Advanced BioMedical Technologies  (OTCPK:ABMT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Advanced BioMedical Technologies LT-Debt-to-Total-Asset Related Terms

Advanced BioMedical Technologies LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies LT-Debt-to-Total-Asset Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.02

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.02 0.01 0.00 0.00

Advanced BioMedical Technologies LT-Debt-to-Total-Asset Calculation

Advanced BioMedical Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Oct. 2020 is calculated as

LT Debt to Total Assets (A: Oct. 2020 )=Long-Term Debt & Capital Lease Obligation (A: Oct. 2020 )/Total Assets (A: Oct. 2020 )
=0.007/0.469
=0.01

Advanced BioMedical Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jul. 2021 is calculated as

LT Debt to Total Assets (Q: Jul. 2021 )=Long-Term Debt & Capital Lease Obligation (Q: Jul. 2021 )/Total Assets (Q: Jul. 2021 )
=0/0.397
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Advanced BioMedical Technologies (ABMT) has a LT-Debt-to-Total-Asset of 0.00 as of Jul. 2021. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' LT-Debt-to-Total-Asset too high?
Advanced BioMedical Technologies' current LT-Debt-to-Total-Asset is 0.00.
How does Advanced BioMedical Technologies' LT-Debt-to-Total-Asset compare to VYCO and ADMT?
Advanced BioMedical Technologies' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current LT-Debt-to-Total-Asset is 0.00 as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.